Gossamer Bio, Inc. (GOSS): debt financing — Gossamer Bio exchanges 90.5% of 5% notes for new 7.5% notes, stock, and warrants

Gossamer Bio, Inc.

$181M of 5% Convertible Senior Notes due 2027 tendered and cancelled (90.5% of outstanding).
Issued $65M of new 7.5% Convertible Senior Secured First Lien Notes due 2030.
Issued 254M common shares, 33.4M prefunded warrants, and 135.8M purchase warrants.
Remaining $18.9M of existing notes outstanding; exchange offer open until June 16, 2026.
Consent solicitation adopted amendments eliminating restrictive covenants in existing indenture.

item 1.01 item 1.02 item 2.03 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Gossamer Bio, Inc. incurred convertible notes of $65,174,000 in aggregate principal amount of New Convertible Notes with U.S. Bank Trust Company, National Association at 7.50% per annum maturing July 1, 2030.

Instrument: convertible notes
Principal: $65,174,000 in aggregate principal amount of New Convertible Notes
Counterparty: U.S. Bank Trust Company, National Association
Rate: 7.50% per annum
Maturity: July 1, 2030
Event: incurrence

Exact text from the filing

the Company issued (i) $65,174,000 in aggregate principal amount of New Convertible Notes

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Gossamer Bio, Inc. entered into Purchase Warrant Agreement with Computershare, Inc., as warrant agent (effective 2026-06-04).

Action: entry
Agreement: equity purchase
Counterparty: Computershare, Inc., as warrant agent
Effective: 2026-06-04

Exact text from the filing

a warrant agreement, dated as of June 4, 2026 (the “Purchase Warrant Agreement”), by and between the Company and Computershare, Inc., as warrant agent (the “Warrant Agent”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Gossamer Bio, Inc. entered into New Convertible Notes Indenture with U.S. Bank Trust Company, National Association, as trustee and collateral agent (effective 2026-06-04).

Action: entry
Agreement: notes offering
Counterparty: U.S. Bank Trust Company, National Association, as trustee and collateral agent
Effective: 2026-06-04

Exact text from the filing

an indenture, dated as of June 4, 2026 (the “New Convertible Notes Indenture”), by and between the Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee and collateral agent (in such capacity, the “Collateral Agent”).

View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

Gossamer Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001728117-26-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.